Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling

• Anjana Bhardwaj ,

  * E-mail: ibedrosian@mdanderson.org (IB); abhardwaj@mdanderson.org (AB)

  Affiliation Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Nivetha Ganesan,

  Affiliation Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Kazunoshin Tachibana,

  Affiliation Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Kimal Rajapakshe,

  Affiliation Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America

  ⨯
• Constance T. Albarracin,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

  ⨯
• Preethi H. Gunaratne,

  Affiliation Department of Biology and Biochemistry, University of Houston, Houston, TX, United States of America

  ⨯
• Cristian Coarfa,

  Affiliation Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America

  ⨯
• Isabelle Bedrosian

  * E-mail: ibedrosian@mdanderson.org (IB); abhardwaj@mdanderson.org (AB)

  Affiliation Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

  ⨯